Signaling Pathways - CK1 - MK2 - Valosin-containing protein (VCP) - CSF-1R
清除全部
- C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂
- B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI)
- B4899 BLZ9451 CitationTarget: CSF-1RSummary: CSF-1R激酶抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂
- B2168 NMS-8733 CitationTarget: Valosin-containing protein (VCP)Summary: VCP/p97抑制剂
- A1655 GW25801 CitationTarget: CSF-1RSummary: CFMS激酶/CSF-1R抑制剂
- A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂
- A3719 PF-670462Target: CK1Summary: CK1 ε/δ抑制剂
- A3342 D44761 CitationTarget: CK1Summary: CK1/ALK5抑制剂